» Articles » PMID: 12408772

Percutaneous Microwave Coagulation Therapy for Lung Cancer

Overview
Specialty Oncology
Date 2002 Nov 1
PMID 12408772
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate the clinical effect, CT image changes and side-effects of percutaneous microwave coagulation therapy for lung cancer.

Methods: CT-guided percutaneous puncture was performed using a needle mono-pole microwave antenna with 65W, 2 450 MHz microwave delivered in 60 seconds to 20 peripheral lung cancer patients, including 8 suffering from primary lung cancer and 12 metastatic lung cancer (totally 28 lesions).

Results: Sixteen patients were alive after having been followed-up for 3 approximately 24 months. All patients showed nodules decreased in size. Diminution of over 50% was observed in 13 nodules and 3, completely disappeared. The overall response rate was 57.1%. Ellipsoid shadow 3.5 cm x 2.5 cm across was observed by CT in lesions immediately after coagulation. Gasification within the coagulated area was observed in a week with a high density in the peripheral region. Consolidation was observed in 3 months and the lesion disappeared 1 year later. Complete tumor necrosis was proved by biopsy. No side-effects or complications were observed.

Conclusion: Percutaneous microwave coagulation therapy is a new safe treatment for lung cancer, giving marked effect but minimum trauma.

Citing Articles

Stereotactic ablative brachytherapy versus percutaneous microwave ablation for early-stage non-small cell lung cancer: a multicenter retrospective study.

Wu C, Cao B, He G, Li Y, Wang W BMC Cancer. 2024; 24(1):304.

PMID: 38448897 PMC: 10916219. DOI: 10.1186/s12885-024-12055-6.


Cost and effectiveness of microwave ablation versus video-assisted thoracoscopic surgical resection for ground-glass nodule lung adenocarcinoma.

Han X, Wei Z, Zhao Z, Yang X, Ye X Front Oncol. 2022; 12:962630.

PMID: 36276106 PMC: 9581221. DOI: 10.3389/fonc.2022.962630.


Microwave ablation for the management of pulmonary inflammatory myofibroblastic tumor: a case report and literature review.

Zhang Y, Zheng G, Meng X, Li Y, Shi D, Yu J Transl Cancer Res. 2022; 10(10):4582-4590.

PMID: 35116315 PMC: 8797413. DOI: 10.21037/tcr-21-1885.


Percutaneous thermal ablation for stage IA non-small cell lung cancer: long-term follow-up.

Narsule C, Sridhar P, Nair D, Gupta A, Oommen R, Ebright M J Thorac Dis. 2017; 9(10):4039-4045.

PMID: 29268414 PMC: 5723816. DOI: 10.21037/jtd.2017.08.142.


Radiofrequency versus microwave ablation for treatment of the lung tumours: LUMIRA (lung microwave radiofrequency) randomized trial.

Macchi M, Belfiore M, Floridi C, Serra N, Belfiore G, Carmignani L Med Oncol. 2017; 34(5):96.

PMID: 28417355 DOI: 10.1007/s12032-017-0946-x.